Oncosil Medical Ltd Cash Flow Reinvestment Rate

Latest as of June 2015: 0.07x

Oncosil Medical Ltd cash flow reinvestment rate. Oncosil Medical Ltd (OSL) has a Cash Flow Reinvestment Rate of 0.07x as of June 2015, reinvesting AU$43.85K (capex AU$43.85K ) from operating cash flow of AU$596.28K. Explore Oncosil Medical Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.07x

(Capex + Investments) / Operating CF

Total Reinvested

AU$43.85K

Capex + Investments

Operating Cash Flow

AU$596.28K

AUD

Capital Expenditures

AU$43.85K

AUD

Cash Flow Reinvestment Rate of Oncosil Medical Ltd (2006–2010)

Cash flow reinvestment rate of Oncosil Medical Ltd from 2006 to 2010. Historical reinvestment intensity for Oncosil Medical Ltd across 2 annual periods. Explore Oncosil Medical Ltd (OSL) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Oncosil Medical Ltd Cash Flow Reinvestment Rate by Year (2006–2010)

Oncosil Medical Ltd cash flow reinvestment rate by year from 2006 to 2010. Year-by-year capital reinvestment analysis for Oncosil Medical Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Oncosil Medical Ltd.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2010	0.20x	AU$30.48K	AU$154.35K	AU$30.48K	▼ -85.8%
2006	1.39x	AU$271.11K	AU$195.51K	AU$271.11K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow